Innocan Phrama Completes Successful Cosmetic Clinical Studies Demonstrating the Efficacy of Its SHIR(TM) CBD Premium Facial Serum on Skin Hydration

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – September 15, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to …

Innocan’s SHIR (TM) Beauty & Science CBD Derma Cosmetics Products Passed Safety Assessments and Have Been Approved for Marketing in the European Union

Herzliya, Israel and Calgary, Alberta–(Newsfile Corp. – August 6, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the “Company” or “Innocan”), is pleased to …

Innocan Pharma Announces Mackie Research’s Institutional Sales Group Issues Enterprise Publication on the Company

Innocan Pharma Corporation (CNSX: INNO) (FSE: IP4) (the “Company” or “Innocan“), is pleased to announce that Mackie Research Capital Corporation’s institutional sales group has issued …